INCOG BioPharma Services Plans Fishers, Indiana, Manufacturing Operations
12/24/2025
The $200 million investment at the company's existing facility will increase its injectable drug product manufacturing capacity, enabling the production of up to 480 million units per year.
"The continued demand from our global biopharma partners and our team's ability to deliver create the opportunity for this next level of investment and expansion," said Cory Lewis, CEO of INCOG BioPharma. "Committing another $200 million and employing nearly 1,000 team members by 2030 underscores our dedication to continue providing world-class, flexible manufacturing capacity while creating generational opportunities for the talented workforce here in central Indiana. This is a vote of confidence in our team, our quality, and our future."
The project is being supported by incentives offered by the State of Indiana.
"INCOG BioPharma's expansion is yet another example of Indiana leading in life sciences and advanced manufacturing. This major investment further positions us as one of the nation's top hubs for innovative drug development and will bring hundreds of new, high-paying jobs to our state. I'm proud to see companies like INCOG choose Indiana as the place to grow," noted Indiana Governor Mike Braun.
INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the biopharmaceutical market.
Project Announcements
Siemens Energy Plans Fort Payne, Alabama, Manufacturing Operations
02/09/2026
Preciball USA Plans Screven County, Georgia, Production Operations
02/09/2026
Mecad USA Plans Tulsa Port of Catoosa, Oklahoma, Manufacturing Campus
02/08/2026
Anduril Industries Plans Long Beach-Lakewood, California, Operations
02/08/2026
Dongwon Autopart Technology Plans Emanuel County, Georgia, Production Operations
02/07/2026
Quantum Machines Plans Chicago, Illinois, Operations
02/06/2026
Most Read
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026